Anaprox, Anaprox DS (naproxen sodium)

Anaprox ® or Anaprox® DS (naproxen sodium) is indicated for:

  • The relief of mild to moderately severe pain, accompanied by inflammation in conditions such as musculo skeletal trauma and post-dental extraction.
  • The relief of pain associated with post-partum cramping and dysmenorrhea.

For complete prescribing information, please consult the Product Monograph.

Dantrium capsules de dantrolene sodique

Dantrium® Capsules (Dantrolene Sodium) are indicated for:

  • Controlling the manifestations of a chronic spasticity of skeletal muscle resulting from such conditions as spinal cord injury, cerebral palsy, multiple sclerosis, and stroke, whenever such spasticity results in a decrease in functional use of residual motor activity.
  • The pre-operative management of malignant hyperthermia-susceptible surgical patients.
  • The post-crisis follow-up management of patients stabilized with the intravenous product (for information regarding the intravenous product see the Dosage and Administration Section of the Dantrium Intravenous Product Monograph).

Dantrium is not indicated in the relief of skeletal muscle spasms due to rheumatic disorders. For complete prescribing information, please consult the Product Monograph. For more information on Dantrium Capsules, please click here to visit the website.

Fucithalmic (Fusidic acid 1% Viscous Eye Drops)

Fucithalmic® Viscous Eye Drops (fusidic acid) are indicated for the treatment of superficial infections of the eye and its adnexa (ie., conjunctivitis) caused by fusidic acid susceptible strains of the designated bacteria in adults and children (≥2 years of age): Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae.

For complete prescribing information, please consult the Product Monograph.

NAPROSYN (naproxen)

Naprosyn® (naproxen) is indicated for:

  • The treatment of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
  • The relief of minor aches and pains in muscles, bones and joints, mild to moderate pain accompanied by inflammation in musculoskeletal injuries (sprains and strains) and primary dysmenorrhea.

For complete prescribing information, please consult the Product Monograph.

Toradol ketorolac tromethamine tablets USP

Orally administered Toradol® (ketorolac tromethamine) is indicated for:

  • The short-term management (not to exceed 5 days for post-surgical patients or 7 days for patients with musculoskeletal pain) of moderate to moderately severe acute pain, including post-surgical pain (such as general, orthopaedic and dental surgery), acute musculoskeletal trauma pain and post-partum uterine cramping pain (see WARNINGS AND PRECAUTIONS and DOSAGE AND ADMINISTRATION).

For complete prescribing information, please consult the Product Monograph.